The $30m that you refer to is only the dividend and capital return. IVA will still own 22% of EXS.Xstrata bought the Cloncurry asset from EXS. It was not a takeover.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor